<?xml-stylesheet type="text/css" href="C:\Users\Fernando\Documents\CIPF\Pharm Pract\Pubmed Central\JATS_OXYGEN\jats.css"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Pract (Granada)</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Pract (Granada)</journal-id><journal-id journal-id-type="publisher-id">Pharm Pract</journal-id><journal-title-group><journal-title>Pharmacy Practice</journal-title></journal-title-group><issn pub-type="ppub">1885-642X</issn><issn pub-type="epub">1886-3655</issn><publisher><publisher-name>Centro de Investigaciones y Publicaciones
Farmaceuticas</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24688618</article-id><article-id pub-id-type="pmc">3969835</article-id><article-id pub-id-type="publisher-id">PhP-390</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The impact of pharmaceutical care on patients with hypertension and
their pharmacists</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Skowron</surname><given-names>Agnieszka</given-names></name><aff><institution>Jagiellonian University</institution>, School of Medicine,
Faculty of Pharmacy, Department of Pharmacoepidemiology and
Pharmacoeconomics, Krakow (<country>Poland</country>).</aff></contrib><contrib contrib-type="author"><name><surname>Polak</surname><given-names>Sebastian</given-names></name><aff><institution>Jagiellonian University</institution>, School of Medicine,
Faculty of Pharmacy, Department of Pharmacoepidemiology and
Pharmacoeconomics, Krakow (<country>Poland</country>).</aff></contrib><contrib contrib-type="author"><name><surname>Brandys</surname><given-names>Jerzy</given-names></name><aff><institution>Jagiellonian University</institution>, School of Medicine,
Faculty of Pharmacy, Department of Pharmacoepidemiology and
Pharmacoeconomics, Krakow (<country>Poland</country>).</aff></contrib></contrib-group><pub-date pub-type="ppub" iso-8601-date="20130331"><season>Apr-Jun</season><year iso-8601-date="2012">2011</year></pub-date><pub-date pub-type="epub" iso-8601-date="20130328"><day>17</day><month>6</month><year iso-8601-date="2012">2011</year></pub-date><volume>9</volume><issue>2</issue><fpage>110</fpage><lpage>115</lpage><history><date date-type="received" iso-8601-date="20130129"><day>17</day><month>12</month><year iso-8601-date="2013">2010</year></date><date date-type="accepted" iso-8601-date="20130321"><day>15</day><month>6</month><year iso-8601-date="2013">2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011, CIPF</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p> This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited. </license-p></license></permissions><abstract><sec sec-type="objective"><title>Objective</title><p>The purpose of the study was to assess the influence of pharmaceutical care
on patients&#x02019; knowledge, quality of life and blood pressure and to determine
whether new type of pharmaceutical services changes the pharmacists&#x02019;
satisfaction and knowledge.</p></sec><sec sec-type="methods"><title>Methods</title><p>Community pharmacies were randomly assigned to study and control group and
pharmacists from both groups included patients with hypertension, who meet
inclusion and exclusion criteria. Study group provided the pharmaceutical
care (education, pharmacotherapy monitoring, detecting and solving drug
related problems) for their patients, while the control group provided the
standard pharmaceutical services (dispensing medicines with or without
counseling). At the beginning and the end of the study pharmacists and
patients filled in the knowledge test. Pharmacists fulfilled also
satisfaction questionnaire. </p></sec><sec sec-type="results"><title>Results</title><p>Survey data were collected from 28 and 56 patients from community pharmacies
in study and control group respectively. At the last meeting the normal
blood pressure achieved 79% and 55% patients in study and control group,
respectively (p&#x0003e;0,05). The pharmaceutical care improved patients&#x02019; knowledge
about disease. Pharmacists from study group, who provided pharmaceutical
care, had higher level of pharmacotherapy knowledge and professional
satisfaction than the control group.</p></sec><sec sec-type="conclusion"><title>Conclusions</title><p>Implementation of pharmaceutical care into the pharmacy practice benefits
both, patients and pharmacists.</p></sec></abstract><kwd-group kwd-group-type="MESH"><kwd>Hypertension</kwd><kwd>Medication Therapy Management</kwd><kwd>Community Pharmacy Services</kwd><kwd>Poland</kwd></kwd-group><funding-group><funding-statement>This research received no specific grant from any funding agency
in the public, commercial, or not-for-profit sectors.</funding-statement></funding-group></article-meta></front><body><sec><title>Introduction</title><p>Both patient-related factors (social-economic status or non-adherence) and factors
related to health care system and medical staff (for example, lack of access to
medical care) is listed within causes for lack of effectiveness of anti-hypertensive
therapy. Effective communication between patient and members of medical team and
appropriate amount of time and resources allocated for patient may increase
effective treatment.<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref> Cooperation between physicians, pharmacist and other medical
personnel, as well as encouragement of patient to systematic control of blood
pressure results in effectiveness improvement of hypertension pharmacotherapy.<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref> Previous studies have demonstrated that involvement of
pharmacists in taking care of patients with hypertension can improve their blood
pressure and increase patients&#x02019; quality of life.<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref><xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref></p><p>Community pharmacists in Poland have not yet implemented the pharmaceutical care into
their practice. The health care system in Poland expects pharmacists only to
dispense medication according to physicians&#x02019; prescription, pharmacists are not
obliged to educate patient or monitor effectiveness or safety of their
pharmacotherapy.</p><p>We conduct the first in Poland intervention study to assess whether pharmaceutical
care as defined by Hepler and Strand<xref rid="B23" ref-type="bibr">23</xref> may
improve the effectiveness of hypertensive therapy. Additional aim of the study was
to evaluate the impact of pharmaceutical care on pharmacists&#x02019; professional
satisfaction and their knowledge of pharmacotherapy of hypertension.</p></sec><sec sec-type="methods"><title>Methods</title><p>Random study with pharmacists from Krakow (Poland) and surroundings were carried out.
Information about the study and invitation for pharmacists were done during their
quarterly meetings organized by Regional Pharmaceutical Chamber in Krakow. As many
as 95 pharmacists from 55 community pharmacies (29 community pharmacies and 61
pharmacists from Krakow and 26 community pharmacies and 34 pharmacists from Krakow
surroundings) signed up to participate in the study. Randomization of community
pharmacies to control and study group was done by generation of random numbers by
computer software. The study and the control group consisted of 28 community
pharmacies (44 pharmacists) and 27 community pharmacies (51 pharmacists),
respectively. After randomization, the initial meeting was carried out separately
for the study and the control group. The aim of the initial meeting was to introduce
the rules of the project and to do the initial evaluation of knowledge and
professional satisfaction of pharmacists. Then, the cycle of trainings was carried
out (three 5-hour trainings) in October and November (2004) only for the study
group. These trainings included detection, classification and monitoring of drug
related problems, pathophysiology of hypertension, risk factors and life style
factors influencing the disease, and rules of pharmacotherapy of hypertension.
Trainers and lecturers were researchers (pharmacists) and physicians (specialists in
arterial hypertension and cardiology). At the final meeting in June 2006 pharmacists
from study and control group once again filled in the knowledge test and
professional satisfaction questionnaire. The pharmacists from control group received
the identical training cycle (three 5-hour trainings) as study group after the final
meeting. Pharmacists in Poland are obliged to get 100 scores (every 5 years) to
maintain their professional pharmacy license. They may get scores for participation
in the professional trainings carried out by institutions accredited by governmental
agency. In our study pharmacists in the control group got 10 scores and pharmacists
in the study group got 15 scores.</p><p>After initial meeting and training for the study group, pharmacists from both groups
started enrolling patients into the project. Men and women age &#x02265;18 years with
hypertension, pharmacologically treated for at least 6 months, who are able to keep
moving independently and contact with surroundings were included. Subjects were
excluded from the study if they had cardiovascular incident (stroke, heart attack)
within the last 6 months or a history of diabetes, asthma, chronic obstructive
pulmonary disease (COPD), mental disease (depression, schizophrenia), or they are
unable to contact with pharmacists independently. The study was approved by local
ethical board and all patients signed out consent form.</p><p>According to pharmacists from the study group, at least 12 meetings from November
(2004) to January (2006) should be done during which a blood pressure should be
measured using sphygmomanometer. In addition, drug related problems should be
detected and solved and patient should be educated about pathophysiology, risk
factors, treatment and style of life with hypertension as well as unassisted blood
pressure measurement. During the first and the last meeting in the community
pharmacy, patient had to fill out questionnaire evaluating his/her knowledge about
hypertension. Besides, in the last meeting, he/she had to fill out questionnaire
(SF-36) about his/her quality of life.<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref> Pharmacists&#x02019; actions were
recorded using Microsoft Access or standard paper forms. All needed items were
provided free-of-charge by researchers&#x02019; team.</p><p>Pharmacists from the control group met their patients included into the study only
two times between November (2004) and January (2006), at least 14 months interval
between this two meetings should be kept. At each meeting patients had to fulfill
questionnaire evaluating his/her knowledge about hypertension and pharmacist
collected information about diagnosed diseases, used medications and results of the
blood pressure measurement. On the last meeting patients had to fill out
additionally the quality of life questionnaire. Pharmacists from the control group
did not do any additional services for patients included into the study, so they did
not monitor the pharmacotherapy and did not educate the patients. Medical history of
patients was documented only in paper forms prepared for the program.</p><p>The researchers&#x02019; team responsible for coordination of this project did not interfere
in any way with the pharmacists&#x02019; actions during this program; however, the website
was prepared, its role was to facilitate exchange of information between
pharmacists. Pharmacists were also informed about the possibility of consulting with
the researchers team by e-mail, phone or personally during the entire period of
project duration. The data recorded by Microsoft Access (only from study group) and
in paper form (both, study and control group) were collected by researchers team
from February to April 2006. The records contained data on patients&#x02019; health
condition, fulfilled questionnaires, DRPs indicated by pharmacists, actions made by
pharmacists to solve DRP and copies of education leaflets prepared by pharmacists
for their patients.</p><p>Statistical analysis. Continuous data were described by mean (standard deviation) and
were compared unpaired t-tests for between group analyses. The Mann-Whitney U test
was used for between group comparisons for variables that were not normally
distributed. Categorical data were described by percentage and were compared by
chi-square test with continuity correction or Fisher&#x02019;s exact test, as appropriate.
The significance level was at 0.05. All analyses were completed using Statistica
version 9.</p></sec><sec sec-type="results"><title>Results</title><p>From all community pharmacies randomized to control and study group only 20 community
pharmacies from the study group (35 pharmacists) and 19 community pharmacies from
the control group (39 pharmacists) included 70 and 123 patients, respectively. Six
community pharmacies (15 pharmacists) from study group and three (10 pharmacists)
from control group resigned before the first meeting with patients. Therefore the
first meeting was carried on for 34 patient and 84 in study and control group,
respectively. Afterward six patients in study group and 28 in control group
resigned, two were moved (from control group) away and the others declared lack of
time to visit community pharmacy or lack of interest in further participation in the
program. The analysis of results was conducted according to Intention of treat (ITT)
and Per Protocol (PP) methods. Data of all patients who had at least two visits and
filled out at the first and last meeting the knowledge questionnaires were included
to the ITT analysis. In addition, pharmacists that took care of those patients
filled out one of the questionnaires were evaluated. Data of patients who had
planned number of visits (&#x02265;12 in the study group and 2 in the control group) were
evaluated in PP analysis only if their pharmacists fulfilled two times the knowledge
and satisfaction questionnaire.</p><p>The control and study group differed in terms of education, age and place of
residence. No difference was detected in the number of dispensed anti-hypertension
medications and other medications dispensed in cardiovascular diseases at the time
of enrollment into the study. Average patient covered by pharmaceutical care had
around 11.8 (SD=3.5) visits in a community pharmacy during 359 (SD=81.2) days (ITT
analysis). In a group which finished the program (PP analysis), 12.9 (SD=2.7) visits
was recorded during 391 (SD=74.4) days of program duration. In the control group,
the time between the first and the last visit was around 439 (SD=19.5) days (ITT
analysis) or 445 (SD=15.8) days (PP analysis). A detailed information about
characteristic of patients included to ITT and PP analysis is presented in <xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristic of patients and the pharmaceutical care in the ITT and PP
analysis at the initial visit.</p></caption><table frame="hsides" rules="all"><thead><tr><th rowspan="2" align="center" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1">ITT analysis</th><th colspan="2" align="center" rowspan="1">PP analysis</th></tr><tr><th align="center" rowspan="1" colspan="1">Study<break/>
(n = 28)</th><th align="center" rowspan="1" colspan="1">Control<break/>
(n = 56)</th><th align="center" rowspan="1" colspan="1">Study<break/>
(n = 10)</th><th align="center" rowspan="1" colspan="1">Control<break/>
(n = 8)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Women (%)</td><td align="center" rowspan="1" colspan="1">17 (60.7)</td><td align="center" rowspan="1" colspan="1">33 (58.9)</td><td align="center" rowspan="1" colspan="1">9 (90)</td><td align="center" rowspan="1" colspan="1">5 (62.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Education (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Elementary</td><td align="center" rowspan="1" colspan="1">2 (7.1)</td><td align="center" rowspan="1" colspan="1">2 (3.6)</td><td align="center" rowspan="1" colspan="1">2 (20)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">Vocational qualification</td><td align="center" rowspan="1" colspan="1">10 (35.7)</td><td align="center" rowspan="1" colspan="1">13 (23.2)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">2 (25)</td></tr><tr><td align="right" rowspan="1" colspan="1">Secondary</td><td align="center" rowspan="1" colspan="1">6 (21.4)</td><td align="center" rowspan="1" colspan="1">20 (35.7)</td><td align="center" rowspan="1" colspan="1">2 (20)</td><td align="center" rowspan="1" colspan="1">3 (37.5)</td></tr><tr><td align="right" rowspan="1" colspan="1">Higher</td><td align="center" rowspan="1" colspan="1">10 (35.7)</td><td align="center" rowspan="1" colspan="1">21 (37.5)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">3 (37.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">31-45</td><td align="center" rowspan="1" colspan="1">1 (3.6)</td><td align="center" rowspan="1" colspan="1">6 (10.7)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1 (12.5)</td></tr><tr><td align="right" rowspan="1" colspan="1">46-60</td><td align="center" rowspan="1" colspan="1">12 (42.9)</td><td align="center" rowspan="1" colspan="1">24 (42.9)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">3 (37.5)</td></tr><tr><td align="right" rowspan="1" colspan="1">61-75</td><td align="center" rowspan="1" colspan="1">11 (39.3)</td><td align="center" rowspan="1" colspan="1">22 (39.3)</td><td align="center" rowspan="1" colspan="1">4 (40)</td><td align="center" rowspan="1" colspan="1">3 (37.5)</td></tr><tr><td align="right" rowspan="1" colspan="1">&#x0003e;75</td><td align="center" rowspan="1" colspan="1">4 (14.3)</td><td align="center" rowspan="1" colspan="1">4 (7.1)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">1 (12.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Residence (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Village</td><td align="center" rowspan="1" colspan="1">6 (21.4)</td><td align="center" rowspan="1" colspan="1">8 (14.3)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">Town &#x0003c; 100.000 inhab</td><td align="center" rowspan="1" colspan="1">12 (42.9)</td><td align="center" rowspan="1" colspan="1">10 (17.9)</td><td align="center" rowspan="1" colspan="1">5 (50)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">City 100.000&#x02013;500.000 inhab</td><td align="center" rowspan="1" colspan="1">1 (3.57)</td><td align="center" rowspan="1" colspan="1">4 (7.1)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">2 (25)</td></tr><tr><td align="right" rowspan="1" colspan="1">City &#x0003e; 500.000 inhab</td><td align="center" rowspan="1" colspan="1">9 (32.1)</td><td align="center" rowspan="1" colspan="1">34 (60.7)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">6 (75)</td></tr><tr><td align="left" rowspan="1" colspan="1">Average blood pressure (SD)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Systolitic</td><td align="center" rowspan="1" colspan="1">144 (10.3)</td><td align="center" rowspan="1" colspan="1">146.9 (19.9)</td><td align="center" rowspan="1" colspan="1">143 (12.4)</td><td align="center" rowspan="1" colspan="1">139.5 (21.7)</td></tr><tr><td align="right" rowspan="1" colspan="1">Diastolic</td><td align="center" rowspan="1" colspan="1">85 (10.2)</td><td align="center" rowspan="1" colspan="1">89.9 (11)</td><td align="center" rowspan="1" colspan="1">83.5 (10.9)</td><td align="center" rowspan="1" colspan="1">90 (11.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Average number of medications used in chronic diseases
(SD)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Totally </td><td align="center" rowspan="1" colspan="1">3.9 (1.9)</td><td align="center" rowspan="1" colspan="1">3.7 (2.2)</td><td align="center" rowspan="1" colspan="1">4.7 (1.3)</td><td align="center" rowspan="1" colspan="1">4.0 (1.6)</td></tr><tr><td align="right" rowspan="1" colspan="1">cardiovascular system* </td><td align="center" rowspan="1" colspan="1">2.9 (1.5)</td><td align="center" rowspan="1" colspan="1">3.1 (1.7)</td><td align="center" rowspan="1" colspan="1">3.3 (1.3)</td><td align="center" rowspan="1" colspan="1">2.9 (1.2)</td></tr><tr><td align="right" rowspan="1" colspan="1">HT**</td><td align="center" rowspan="1" colspan="1">2.0 (0.8)</td><td align="center" rowspan="1" colspan="1">2.2 (0.9)</td><td align="center" rowspan="1" colspan="1">2.2 (1.0)</td><td align="center" rowspan="1" colspan="1">1.9 (0.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Visits within a framework of PC (SD)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Average number of visits</td><td align="center" rowspan="1" colspan="1">11.8 (3.5)</td><td align="center" rowspan="1" colspan="1">2 (0)</td><td align="center" rowspan="1" colspan="1">12.9 (2.73)</td><td align="center" rowspan="1" colspan="1">2 (0)</td></tr><tr><td align="right" rowspan="1" colspan="1">Length (in days) of PC</td><td align="center" rowspan="1" colspan="1">359.2 (81.2)</td><td align="center" rowspan="1" colspan="1">438.8 (19.5)</td><td align="center" rowspan="1" colspan="1">390.7 (74.4)</td><td align="center" rowspan="1" colspan="1">445.4 (15.8)</td></tr><tr><td colspan="5" align="left" rowspan="1">*groups C01, C04-C08, C10 in ATC classification,
**medication from C02, C03, C09 group, HT-arterial hypertension, PC &#x02013;
pharmaceutical care</td></tr></tbody></table></table-wrap><p>At the last visit it was observed that patients from the study group have been taken
one antihypertensive and two cardiovascular diseases medications more than they
declared at the initial visit. The number of dispensed medications did not change in
the control group. Detailed data are presented in <xref ref-type="table" rid="T2">Table 2</xref>. Increased number of dispensed medications did not have any
effect on therapy efficacy, which was measured as an average decrease in arterial
blood pressure at the end of pharmaceutical care. However, at the end of the program
it was demonstrated that the normal blood pressure was in 22 out of 28 patients
(79%) in the study group, and in 31 out of 56 patients (55%) in the control group
(chi-square Pearson test, p&#x0003c;0.05) according to ITT analysis. Among the patients
included in the full pharmaceutical care program (PP analysis), the normal blood
pressure was recorded in 8 out of 10 patients (80%) from the study group, and in 6
out of 8 patients (75%) in the control group (p=0.80).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>The impact of the pharmaceutical care on the number of medications used and
on level of blood pressure.</p></caption><table frame="hsides" rules="all"><thead><tr><th rowspan="2" align="center" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1">ITT analysis</th><th colspan="3" align="center" rowspan="1">PP analysis</th></tr><tr><th align="center" rowspan="1" colspan="1">Study<break/> (n = 28)</th><th align="center" rowspan="1" colspan="1">Control<break/> (n = 56)</th><th align="center" rowspan="1" colspan="1">p<sup>a</sup></th><th align="center" rowspan="1" colspan="1">Study<break/> (n = 10)</th><th align="center" rowspan="1" colspan="1">Control<break/> (n = 8)</th><th align="center" rowspan="1" colspan="1">p<sup>b</sup></th></tr></thead><tbody><tr><td colspan="7" align="left" rowspan="1">Number of medications used on last visit
(SD)</td></tr><tr><td align="right" rowspan="1" colspan="1">Totally</td><td align="center" rowspan="1" colspan="1">5.4 (2.2)</td><td align="center" rowspan="1" colspan="1">4.1 (2.5)</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">7.0 (2.1)</td><td align="center" rowspan="1" colspan="1">4.3 (3.1)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="right" rowspan="1" colspan="1">cardiovascular system* </td><td align="center" rowspan="1" colspan="1">4.4 (1.8)</td><td align="center" rowspan="1" colspan="1">3.0 (1.4)</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">5.4 (2.2)</td><td align="center" rowspan="1" colspan="1">3.0 (1.4)</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td align="right" rowspan="1" colspan="1"> HT**</td><td align="center" rowspan="1" colspan="1">2.6 (1.3)</td><td align="center" rowspan="1" colspan="1">2.2 (0.9)</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">3.3 (1.4)</td><td align="center" rowspan="1" colspan="1">2.0 (1.1)</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td colspan="7" align="left" rowspan="1">Level of arterial blood pressure (mmHg) on
last visit (SD)</td></tr><tr><td align="right" rowspan="1" colspan="1">Systolitic</td><td align="center" rowspan="1" colspan="1">138 (12.5)</td><td align="center" rowspan="1" colspan="1">142 (19.6)</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">136 (14.9)</td><td align="center" rowspan="1" colspan="1">152 (43.7)</td><td align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td align="right" rowspan="1" colspan="1">Diastolic</td><td align="center" rowspan="1" colspan="1">83 (9.9)</td><td align="center" rowspan="1" colspan="1">88 (9.2)</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">79 (9.6)</td><td align="center" rowspan="1" colspan="1">93 (19.7)</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td colspan="7" align="left" rowspan="1">a- t- test for independent groups
(comparison of the study and control group), b-U-Mann-Whitney test
(comparison of the study and control group), *groups C01, C04-C08,
C10 in ATC classification, **medication from C02, C03, C09 group,
HT-arterial hypertension</td></tr></tbody></table></table-wrap><p>Before the beginning of the study, the level of patient knowledge regarding
hypertension in the study and the control group was similar, 24.8 (SD=5.3) and 26.1
(SD=4.5) points, respectively. No higher level of knowledge in general were observed
in patients of the study and the control group, 28.3 (SD=4.2) and 27 (SD=4.5)
points, respectively (p = 0.2) at the end of the study. However, pharmaceutical care
increased the knowledge about the disease (ITT analysis) in the study group it was
8.1 points (SD=2.2) in comparison with 6.8 (SD=2.4) points in the control group
(t-test, p&#x0003c;0.05) (<xref ref-type="table" rid="T3">Table 3</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Progress in the knowledge of patients covered or not by the pharmaceutical
care.</p></caption><table frame="hsides" rules="all"><thead><tr><th rowspan="2" align="center" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1">ITT analysis</th><th colspan="3" align="center" rowspan="1">PP analysis</th></tr><tr><th align="center" rowspan="1" colspan="1">Study<break/> (n = 28) <break/> Mean (SD)</th><th align="center" rowspan="1" colspan="1">Control<break/> (n = 56) <break/> Mean (SD)</th><th align="center" rowspan="1" colspan="1">p<sup>a</sup></th><th align="center" rowspan="1" colspan="1">Study<break/> (n = 10) <break/> Mean (SD)</th><th align="center" rowspan="1" colspan="1">Control<break/> (n = 8) <break/> Mean (SD)</th><th align="center" rowspan="1" colspan="1">p<sup>b</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Knowledge progress</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Totally</td><td align="center" rowspan="1" colspan="1">3.2 (3.03)</td><td align="center" rowspan="1" colspan="1">1.3 (5.3)</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">3.4 (5.6)</td><td align="center" rowspan="1" colspan="1">2.25 (3.7)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="right" rowspan="1" colspan="1">About disease</td><td align="center" rowspan="1" colspan="1">1.5 (2.4)</td><td align="center" rowspan="1" colspan="1">-0.2 (2.7)</td><td align="center" rowspan="1" colspan="1">0.006</td><td align="center" rowspan="1" colspan="1">1.8 (2.5)</td><td align="center" rowspan="1" colspan="1">0.5 (1.4)</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="right" rowspan="1" colspan="1">About diet</td><td align="center" rowspan="1" colspan="1">-1.1 (3.5)</td><td align="center" rowspan="1" colspan="1">1.1 (3.1)</td><td align="center" rowspan="1" colspan="1">0.92</td><td align="center" rowspan="1" colspan="1">1.6 (3.9)</td><td align="center" rowspan="1" colspan="1">2 (1.7)</td><td align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td align="right" rowspan="1" colspan="1">About medications</td><td align="center" rowspan="1" colspan="1">0.5 (1.5)</td><td align="center" rowspan="1" colspan="1">-0.1 (2.01)</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">0.1 (0.99)</td><td align="center" rowspan="1" colspan="1">0.25 (1.8)</td><td align="center" rowspan="1" colspan="1">0.75</td></tr><tr><td align="right" rowspan="1" colspan="1">About health attitude</td><td align="center" rowspan="1" colspan="1">0.11 (1.2)</td><td align="center" rowspan="1" colspan="1">0.1 (1.3)</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">-0.1 (1.5)</td><td align="center" rowspan="1" colspan="1">-0.5 (1.3)</td><td align="center" rowspan="1" colspan="1">0.59</td></tr><tr><td colspan="7" align="left" rowspan="1">a- t- test for independent groups (study
vs. control group), b-U-Mann-Whitney test (study vs. control group).
</td></tr></tbody></table></table-wrap><p>Analysis of health-related quality of life was done by filling out the SF-36
questionnaire when the study was finished. No effect of pharmaceutical care on
improvement of quality of life was observed in ITT or PP analysis.</p><p>Additionally, impact of pharmaceutical care on knowledge and professional
satisfaction of pharmacists were evaluated. An increase of knowledge in relation to
therapy and pathology of hypertension was observed during both ITT and PP analysis
in pharmacists from the study group. During PP analysis, the improvement in
knowledge was observed in all pharmacists (100%) in the study group, whereas only
one person (12.5%) demonstrated better knowledge in the control group (chi-square
Pearson test, p&#x0003c;0.05). Individual data are presented in <xref ref-type="table" rid="T4">Table 4</xref>.</p><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><p>The impact of the pharmaceutical care on the knowledge and professional
satisfaction of pharmacists.</p></caption><table frame="hsides" rules="all"><thead><tr><th rowspan="2" align="center" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1">ITT analysis</th><th colspan="3" align="center" rowspan="1">PP analysis</th></tr><tr><th align="center" rowspan="1" colspan="1">Study<break/>
(n = 28) <break/>
Mean (SD)</th><th align="center" rowspan="1" colspan="1">Control<break/>
(n = 56) <break/>
Mean (SD)</th><th align="center" rowspan="1" colspan="1">pa</th><th align="center" rowspan="1" colspan="1">Study<break/>
(n = 10) <break/>
Mean (SD)</th><th align="center" rowspan="1" colspan="1">Control<break/>
(n = 8) <break/>
Mean (SD)</th><th align="center" rowspan="1" colspan="1">pb</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Knowledge</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Before the PC</td><td align="center" rowspan="1" colspan="1">17.3 (3.3)</td><td align="center" rowspan="1" colspan="1">18.1 (4.3)</td><td align="center" rowspan="1" colspan="1">0.51</td><td align="center" rowspan="1" colspan="1">15.0 (3.4)</td><td align="center" rowspan="1" colspan="1">20.4 (4.2)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="right" rowspan="1" colspan="1">After the PC</td><td align="center" rowspan="1" colspan="1">22.9 (3.4)</td><td align="center" rowspan="1" colspan="1">20.1 (2.33)</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">22.3 (2.6)</td><td align="center" rowspan="1" colspan="1">20.1 (4.3)</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="right" rowspan="1" colspan="1">Difference</td><td align="center" rowspan="1" colspan="1">4.44 (1.9)</td><td align="center" rowspan="1" colspan="1">-0.3 (1.9)</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">7.3 (4.0)</td><td align="center" rowspan="1" colspan="1">-0.3 (1.9)</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Satisfaction**</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="right" rowspan="1" colspan="1">Before the PC</td><td align="center" rowspan="1" colspan="1">2.4 (2.7)</td><td align="center" rowspan="1" colspan="1">3.3 (2.2)</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">1.9 (2.0)</td><td align="center" rowspan="1" colspan="1">3.4 (1.4)</td><td align="center" rowspan="1" colspan="1">0.10</td></tr><tr><td align="right" rowspan="1" colspan="1">After the PC</td><td align="center" rowspan="1" colspan="1">2.7 (2.4)</td><td align="center" rowspan="1" colspan="1">1.5 (3.6)</td><td align="center" rowspan="1" colspan="1">0.3</td><td align="center" rowspan="1" colspan="1">2.6 (3.4)</td><td align="center" rowspan="1" colspan="1">1.1 (4.1)</td><td align="center" rowspan="1" colspan="1">0.41</td></tr><tr><td align="right" rowspan="1" colspan="1">Difference</td><td align="center" rowspan="1" colspan="1">1.1 (3.4)</td><td align="center" rowspan="1" colspan="1">-1.8 (3.7)</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.7 (4.5)</td><td align="center" rowspan="1" colspan="1">-2.3 (3.7)</td><td align="center" rowspan="1" colspan="1">015</td></tr><tr><td colspan="7" align="left" rowspan="1">PC-Pharmaceutical care, * maximum number of
points in the test: 30, **maximum number of points in the questionnaire:
7, a- t- test for independent groups (study vs. control group), b-U-Mann-Whitney
test (study vs. control group)</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study had limitation and the results obtained have to be considered with these
limitations. The randomization of community pharmacies to the study and control
group were done due to avoid unintended increase in quality of standard
pharmaceutical services, but it might have influenced the number and characteristic
of patients enrolled into the study and control group. Assignment to the study group
could be the reason for resignation from the study of a large part of community
pharmacies. Despite this limitation we did not observe the differences in
characteristic of patients included in study and control group.</p><p>The significant difference in knowledge about disease between study and control group
was observed at the end of the study. Subjects in the study group at the end of
study were receiving higher number of medications comparing to the control group. At
the end of the program more patients in study group (79%) then in control group
(55%) obtained at least high regular level of blood pressure.<xref rid="B26" ref-type="bibr">26</xref></p><p>In agreement with Hunt <italic>et al</italic>. study<xref rid="B10" ref-type="bibr">10</xref>, it was demonstrated that inclusion of pharmacist to monitor
pharmacotherapy and provide pharmaceutical care resulted in increase in number of
used antihypertensive and cardiovascular disease medications.</p><p>Pharmaceutical care had beneficial effect on therapy results, because at the last
meeting normal values of arterial blood pressure (&#x02264;140/90 mmHg) achieved 79% of
patients from the study group had and only 55% patients in the control group.
However we do not know whether it is due to increased number of medications used by
patient in study group or due to education on lifestyle provided by pharmacists.</p><p>Our study demonstrated that pharmaceutical care also had positive effect on patient&#x02019;s
knowledge about disease. Improvement in the patient&#x02019;s knowledge may have a positive
effect on their health behaviors and may result to better level of the patient
health.<xref rid="B27" ref-type="bibr">27</xref></p><p>No significant difference in the quality of life was demonstrated between the study
and the control group after the end of the program. In other studies, not only
positive effect of the pharmaceutical care on quality of life<xref rid="B28" ref-type="bibr">28</xref> was demonstrated but also lack of positive impact was
described.<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B29" ref-type="bibr">29</xref></p><p>Pharmaceutical care requires appropriate education of the pharmacist. During
pharmaceutical care, the pharmacist has a chance to improve his/her knowledge and
skills.<xref rid="B30" ref-type="bibr">30</xref> In Poland, the evaluation of
the impact of the pharmaceutical care on pharmacists&#x02019; knowledge and satisfaction was
carried out for the first time. It was demonstrated that expanding professional
activity of pharmacists had beneficial effect on their professional satisfaction.
Before beginning the study, pharmacists randomized to study group demonstrated
significantly lower professional satisfaction than pharmacists in control group. At
the end of the study, the job satisfaction was similar for pharmacists from both
groups. In addition, there was a significant increase in satisfaction level in
pharmacists conducting pharmaceutical care compared to the control group in which
almost double decrease in the work satisfaction occurred. Moreover, studies done all
over the world have demonstrated that work with patient increases pharmacist
satisfaction.<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B32" ref-type="bibr">32</xref></p><p>A small number of patients were covered by the whole program of pharmaceutical care,
which prevented the researchers from making conclusions about effectiveness of such
type of actions in Polish population. However, the obtained results were a point of
reference for further actions in relation to implementation of pharmaceutical care
in Poland and its effectiveness assessment.</p></sec><sec sec-type="conclusion"><title>Conclusions</title><p>More patients who received pharmaceutical care had controlled blood pressure as
compared to the group of patients using standard pharmaceutical services. The
pharmaceutical care also had positive effect on the patients&#x02019; knowledge about
disease. Moreover, pharmacists, who provide pharmaceutical care improved their
pharmacotherapy knowledge and had better satisfaction from their work.</p></sec></body><back><fn-group><fn><p>Competing interests: There are no conflicts of interest to be disclosed.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group><name><surname>Borzecki</surname><given-names>AM</given-names></name><name><surname>Oliveria</surname><given-names>SA</given-names></name><name><surname>Berlowitz</surname><given-names>DR</given-names></name></person-group><article-title>Barriers to hypertension control</article-title><source>Am Heart J</source><year>2005</year><volume>149</volume><fpage>785</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">15894958</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group><name><surname>Berlowitz</surname><given-names>DR</given-names></name><name><surname>Ash</surname><given-names>AS</given-names></name><name><surname>Hickey</surname><given-names>EC</given-names></name><name><surname>Friedman</surname><given-names>RH</given-names></name><name><surname>Glickman</surname><given-names>M</given-names></name><name><surname>Kader</surname><given-names>B</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Inadequate management of blood pressure in a hypertensive
population</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><fpage>1957</fpage><lpage>1963</lpage><pub-id pub-id-type="pmid">9869666</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group><name><surname>Degli Esposti</surname><given-names>E</given-names></name><name><surname>Di Martino</surname><given-names>M</given-names></name><name><surname>Sturani</surname><given-names>A</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name><name><surname>Dradi</surname><given-names>C</given-names></name><name><surname>Falcinelli</surname><given-names>S</given-names></name><name><surname>Buda</surname><given-names>S</given-names></name></person-group><article-title>Risk factors for uncontrolled hypertension in
Italy</article-title><source>J Hum Hypertens</source><year>2004</year><volume>18</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">14973516</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group><name><surname>Jokisalo</surname><given-names>E</given-names></name><name><surname>Kumpusalo</surname><given-names>E</given-names></name><name><surname>Enlund</surname><given-names>H</given-names></name><name><surname>Takala</surname><given-names>J</given-names></name></person-group><article-title>Patients' perceived problems with hypertension and attitudes
towards medical treatment</article-title><source>J Hum Hypertens</source><year>2001</year><volume>15</volume><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">11687918</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group><name><surname>Hedner</surname><given-names>T</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Narkiewicz</surname><given-names>K</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name></person-group><article-title>Achieving better blood pressure control</article-title><source>Blood Press Suppl</source><year>2008</year><volume>1</volume><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18705529</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group><name><surname>Harmon</surname><given-names>G</given-names></name><name><surname>Lefante</surname><given-names>J</given-names></name><name><surname>Krousel-Wood</surname><given-names>M</given-names></name></person-group><article-title>Overcoming barriers: the role of providers in improving patient
adherence to antihypertensive medications</article-title><source>Curr Opin Cardiol</source><year>2006</year><volume>21</volume><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">16755199</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group><name><surname>Bogden</surname><given-names>PE</given-names></name><name><surname>Abbott</surname><given-names>RD</given-names></name><name><surname>Williamson</surname><given-names>P</given-names></name><name><surname>Onopa</surname><given-names>JK</given-names></name><name><surname>Koontz</surname><given-names>LM</given-names></name></person-group><article-title>Comparing standard care with a physician and pharmacist team
approach for uncontrolled hypertension</article-title><source>J Gen Intern Med</source><year>1998</year><volume>13</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">9824519</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group><name><surname>Cuspidi</surname><given-names>C</given-names></name><name><surname>Meani</surname><given-names>S</given-names></name><name><surname>Fusi</surname><given-names>V</given-names></name><name><surname>Salerno</surname><given-names>M</given-names></name><name><surname>Valerio</surname><given-names>C</given-names></name><name><surname>Severgnini</surname><given-names>B</given-names></name><name><surname>Catini</surname><given-names>E</given-names></name><name><surname>Leonetti</surname><given-names>G</given-names></name><name><surname>Magrini</surname><given-names>F</given-names></name><name><surname>Zanchetti</surname><given-names>A</given-names></name></person-group><article-title>Home blood pressure measurement and its relationship with blood
pressure control in a large selected hypertensive population</article-title><source>J Hum Hypertens</source><year>2004</year><volume>18</volume><fpage>725</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">15103315</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name></person-group><article-title>Improving hypertension control rates: technology, people, or
systems?</article-title><source>JAMA</source><year>2008</year><volume>299</volume><fpage>2896</fpage><lpage>2898</lpage><pub-id pub-id-type="pmid">18577736</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group><name><surname>Hunt</surname><given-names>JS</given-names></name><name><surname>Siemienczuk</surname><given-names>J</given-names></name><name><surname>Pape</surname><given-names>G</given-names></name><name><surname>Rozenfeld</surname><given-names>Y</given-names></name><name><surname>MacKay</surname><given-names>J</given-names></name><name><surname>LeBlanc</surname><given-names>BH</given-names></name><name><surname>Touchette</surname><given-names>D</given-names></name></person-group><article-title>A randomized controlled trial of team-based care: impact of
physician-pharmacist collaboration on uncontrolled
hypertension</article-title><source>J Gen Intern Med</source><year>2008</year><volume>23</volume><fpage>1966</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">18815843</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group><name><surname>Von Muenster</surname><given-names>SJ</given-names></name><name><surname>Carter</surname><given-names>BL</given-names></name><name><surname>Weber</surname><given-names>CA</given-names></name><name><surname>Ernst</surname><given-names>ME</given-names></name><name><surname>Milchak</surname><given-names>JL</given-names></name><name><surname>Steffensmeier</surname><given-names>JJ</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>Description of pharmacist interventions during
physician-pharmacist co-management of hypertension</article-title><source>Pharm World Sci</source><year>2008</year><volume>30</volume><fpage>128</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">17710561</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group><name><surname>McLean</surname><given-names>DL</given-names></name><name><surname>McAlister</surname><given-names>FA</given-names></name><name><surname>Johnson</surname><given-names>JA</given-names></name><name><surname>King</surname><given-names>KM</given-names></name><name><surname>Makowsky</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>CA</given-names></name><name><surname>Tsuyuki</surname><given-names>RT</given-names></name></person-group><article-title>A randomized trial of the effect of community pharmacist and
nurse care on improving blood pressure management in patients with diabetes
mellitus: study of cardiovascular risk intervention by
pharmacists-hypertension (SCRIP-HTN)</article-title><source>Arch Intern Med</source><year>2008</year><volume>168</volume><fpage>2355</fpage><lpage>2361</lpage><pub-id pub-id-type="pmid">19029501</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group><name><surname>Chabot</surname><given-names>I</given-names></name><name><surname>Moisan</surname><given-names>J</given-names></name><name><surname>Gregoire</surname><given-names>JP</given-names></name><name><surname>Milot</surname><given-names>A</given-names></name></person-group><article-title>Pharmacist intervention program for control of
hypertension</article-title><source>Ann Pharmacother</source><year>2003</year><volume>37</volume><fpage>1186</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">12921497</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group><name><surname>Cote</surname><given-names>I</given-names></name><name><surname>Moisan</surname><given-names>J</given-names></name><name><surname>Chabot</surname><given-names>I</given-names></name><name><surname>Gregoire</surname><given-names>JP</given-names></name></person-group><article-title>Health-related quality of life in hypertension: impact of a
pharmacy intervention program</article-title><source>J Clin Pharm Ther</source><year>2005</year><volume>30</volume><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">15985049</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group><name><surname>Green</surname><given-names>BB</given-names></name><name><surname>Cook</surname><given-names>AJ</given-names></name><name><surname>Ralston</surname><given-names>JD</given-names></name><name><surname>Fishman</surname><given-names>PA</given-names></name><name><surname>Catz</surname><given-names>SL</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Carrell</surname><given-names>D</given-names></name><name><surname>Tyll</surname><given-names>L</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Thompson</surname><given-names>RS</given-names></name></person-group><article-title>Effectiveness of home blood pressure monitoring, Web
communication, and pharmacist care on hypertension control: a randomized
controlled trial</article-title><source>JAMA</source><year>2008</year><volume>299</volume><fpage>2857</fpage><lpage>2867</lpage><pub-id pub-id-type="pmid">18577730</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group><name><surname>Green</surname><given-names>BB</given-names></name><name><surname>Ralston</surname><given-names>JD</given-names></name><name><surname>Fishman</surname><given-names>PA</given-names></name><name><surname>Catz</surname><given-names>SL</given-names></name><name><surname>Cook</surname><given-names>A</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Tyll</surname><given-names>L</given-names></name><name><surname>Carrell</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>RS</given-names></name></person-group><article-title>Electronic communications and home blood pressure monitoring
(e-BP) study: design, delivery, and evaluation framework</article-title><source>Contemp Clin Trials</source><year>2008</year><volume>29</volume><fpage>376</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">17974502</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group><name><surname>Erhun</surname><given-names>WO</given-names></name><name><surname>Agbani</surname><given-names>EO</given-names></name><name><surname>Bolaji</surname><given-names>EE</given-names></name></person-group><article-title>Positive benefits of a pharmacist-managed hypertension clinic in
Nigeria</article-title><source>Public Health</source><year>2005</year><volume>119</volume><fpage>792</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">15990127</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group><name><surname>Mehos</surname><given-names>BM</given-names></name><name><surname>Saseen</surname><given-names>JJ</given-names></name><name><surname>MacLaughlin</surname><given-names>EJ</given-names></name></person-group><article-title>Effect of pharmacist intervention and initiation of home blood
pressure monitoring in patients with uncontrolled
hypertension</article-title><source>Pharmacotherapy</source><year>2000</year><volume>20</volume><fpage>1384</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">11079287</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group><name><surname>McConnell</surname><given-names>KJ</given-names></name><name><surname>Zadvorny</surname><given-names>EB</given-names></name><name><surname>Hardy</surname><given-names>AM</given-names></name><name><surname>Delate</surname><given-names>T</given-names></name><name><surname>Rasmussen</surname><given-names>JR</given-names></name><name><surname>Merenich</surname><given-names>JA</given-names></name></person-group><article-title>Coronary artery disease and hypertension: outcomes of a
pharmacist-managed blood pressure program</article-title><source>Pharmacotherapy</source><year>2006</year><volume>26</volume><fpage>1333</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">16945056</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group><name><surname>Reid</surname><given-names>F</given-names></name><name><surname>Murray</surname><given-names>P</given-names></name><name><surname>Storrie</surname><given-names>M</given-names></name></person-group><article-title>Implementation of a pharmacist-led clinic for hypertensive
patients in primary care--a pilot study</article-title><source>Pharm World Sci</source><year>2005</year><volume>27</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">16096888</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group><name><surname>Aguwa</surname><given-names>CN</given-names></name><name><surname>Ukwe</surname><given-names>CV</given-names></name><name><surname>Ekwunife</surname><given-names>OI</given-names></name></person-group><article-title>Effect of pharmaceutical care program on blood pressure and
quality of life in a Nigerian pharmacy</article-title><source>Pharm World Sci</source><year>2008</year><volume>30</volume><fpage>107</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">17703369</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group><name><surname>Zillich</surname><given-names>AJ</given-names></name><name><surname>Sutherland</surname><given-names>JM</given-names></name><name><surname>Kumbera</surname><given-names>PA</given-names></name><name><surname>Carter</surname><given-names>BL</given-names></name></person-group><article-title>Hypertension outcomes through blood pressure monitoring and
evaluation by pharmacists (HOME study)</article-title><source>J Gen Intern Med</source><year>2005</year><volume>20</volume><fpage>1091</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">16423096</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group><name><surname>Hepler</surname><given-names>CD</given-names></name><name><surname>Strand</surname><given-names>LM</given-names></name></person-group><article-title>Opportunities and responsibilities in pharmaceutical
care</article-title><source>Am J Hosp Pharm</source><year>1990</year><volume>47</volume><fpage>533</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">2316538</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group><name><surname>Ware</surname><given-names>JE</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name></person-group><article-title>The MOS 36-item short-form Health Survey (SF-36): I. Conceptual
Framework and Item Selection</article-title><source>Med Care</source><year>1992</year><volume>30</volume><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">1593914</pub-id></element-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="book"><person-group><name><surname>Ware</surname><given-names>JE</given-names></name><name><surname>Kosinski</surname><given-names>M</given-names></name><name><surname>Dewey</surname><given-names>JE</given-names></name></person-group>
<source>How to score Version 2 of the SF-36 Health
Survey (Standard &#x00026; Acute Forms</source>). <publisher-loc>Lincoln,
TI</publisher-loc>: <publisher-name>QualityMetric
Incorporated</publisher-name>, <year>2000</year></mixed-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>De Backer</surname><given-names>G</given-names></name><name><surname>Dominiczak</surname><given-names>A</given-names></name><name><surname>Cifkova</surname><given-names>R</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Germano</surname><given-names>G</given-names></name><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Heagerty</surname><given-names>AM</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><name><surname>Narkiewicz</surname><given-names>K</given-names></name><name><surname>Ruilope</surname><given-names>L</given-names></name><name><surname>Rynkiewicz</surname><given-names>A</given-names></name><name><surname>Schmieder</surname><given-names>RE</given-names></name><name><surname>Boudier</surname><given-names>HA</given-names></name><name><surname>Zanchetti</surname><given-names>A</given-names></name><collab>ESH-ESC Task Force on the Management of Arterial
Hypertension</collab></person-group><article-title>2007 ESH-ESC Practice Guidelines for the Management of Arterial
Hypertension: ESH-ESC Task Force on the Management of Arterial
Hypertension</article-title><source>J Hypertens</source><year>2007</year><volume>25</volume><fpage>1751</fpage><lpage>1762</lpage><pub-id pub-id-type="pmid">17762635</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group><name><surname>Morisky</surname><given-names>DE</given-names></name><name><surname>Levine</surname><given-names>DM</given-names></name><name><surname>Green</surname><given-names>LW</given-names></name><name><surname>Shapiro</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>RP</given-names></name><name><surname>Smith</surname><given-names>CR</given-names></name></person-group><article-title>Five-year blood pressure control and mortality following health
education for hypertensive patients</article-title><source>Am J Public Health</source><year>1983</year><volume>73</volume><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">6849473</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group><name><surname>Carter</surname><given-names>BL</given-names></name><name><surname>Barnette</surname><given-names>DJ</given-names></name><name><surname>Chrischilles</surname><given-names>E</given-names></name><name><surname>Mazzotti</surname><given-names>GJ</given-names></name><name><surname>Asali</surname><given-names>ZJ</given-names></name></person-group><article-title>Evaluation of hypertensive patients after care provided by
community pharmacists in a rural setting</article-title><source>Pharmacotherapy</source><year>1997</year><volume>17</volume><fpage>1274</fpage><lpage>1285</lpage><pub-id pub-id-type="pmid">9399611</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group><name><surname>Erickson</surname><given-names>SR</given-names></name><name><surname>Slaughter</surname><given-names>R</given-names></name><name><surname>Halapy</surname><given-names>H</given-names></name></person-group><article-title>Pharmacists' ability to influence outcomes of hypertension
therapy</article-title><source>Pharmacotherapy</source><year>1997</year><volume>17</volume><fpage>140</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">9017775</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group><name><surname>Villeneuve</surname><given-names>J</given-names></name><name><surname>Lamarre</surname><given-names>D</given-names></name><name><surname>Lussier</surname><given-names>MT</given-names></name><name><surname>Vanier</surname><given-names>MC</given-names></name><name><surname>Genest</surname><given-names>J</given-names></name><name><surname>Blais</surname><given-names>L</given-names></name><name><surname>Hudon</surname><given-names>E</given-names></name><name><surname>Perreault</surname><given-names>S</given-names></name><name><surname>Berbiche</surname><given-names>D</given-names></name><name><surname>Lalonde</surname><given-names>L</given-names></name></person-group><article-title>Physician-pharmacist collaborative care for dyslipidemia
patients: knowledge and skills of community pharmacists</article-title><source>J Contin Educ Health Prof</source><year>2009</year><volume>29</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">19998453</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group><name><surname>Collins</surname><given-names>C</given-names></name><name><surname>Kramer</surname><given-names>A</given-names></name><name><surname>O'Day</surname><given-names>ME</given-names></name><name><surname>Low</surname><given-names>MB</given-names></name></person-group><article-title>Evaluation of patient and provider satisfaction with a
pharmacist-managed lipid clinic in a Veterans Affairs medical
center</article-title><source>Am J Health Syst Pharm</source><year>2006</year><volume>63</volume><fpage>1723</fpage><lpage>1727</lpage><pub-id pub-id-type="pmid">16960256</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group><name><surname>Lapane</surname><given-names>KL</given-names></name><name><surname>Hughes</surname><given-names>CM</given-names></name></person-group><article-title>Baseline job satisfaction and stress among pharmacists and
pharmacy technicians participating in the Fleetwood Phase III
Study</article-title><source>Consult Pharm</source><year>2004</year><volume>19</volume><fpage>1029</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">16553486</pub-id></element-citation></ref></ref-list></back></article>